Search

everythinglearnresearchcommunity

for

Search:↓

Experts agree that PCOS affects women's health in complex ways, but more research is needed to understand and treat it effectively.

Experts recommend using evidence-based methods to diagnose and treat hirsutism, focusing on symptoms and underlying causes.

The Rotterdam Study found risk factors for elderly diseases, links between lifestyle and genetics with health conditions, and aimed to explore new areas like DNA methylation and sensory input effects on brain function.

Women with the NIH type of PCOS have more obesity and higher risk of diabetes and heart disease than those with other types of PCOS.

PCOS is common among Chinese women of reproductive age and linked to serious metabolic and reproductive issues, especially in obese women.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

Insulin resistance and obesity are key factors in the development and worsening of polycystic ovary syndrome, and lifestyle changes are important for managing it.

About 7% to 15% of Iranian women have polycystic ovary syndrome, depending on the criteria used to diagnose it.

Spironolactone is a safe and effective treatment for reducing excessive hair growth in women.

Lower doses of treatments for hirsutism and acne in PCOS are effective and cause fewer side effects.

Flutamide is more effective and has fewer side effects than spironolactone for treating hirsutism.

Women with PCOS face higher risks of diabetes and heart disease, and these risks increase with obesity.

Obesity worsens PCOS symptoms, and PCOS may lead to more weight gain; managing both requires a holistic approach that includes mental health.

Testosterone's muscle-building effects do not require its conversion to DHT.

People with PCOS, especially if obese, often have NAFLD, linked to obesity, insulin resistance, and high androgen levels.

Cyproterone acetate-estrogen most effective for hirsutism, but consider side effects and patient needs.

The document concludes that proper diagnosis and a multidisciplinary approach are crucial for managing Congenital Adrenal Hyperplasia effectively.

An mFG score of 5 or more indicates above-normal hair growth in Southern Chinese women.

The document concludes that accurate diagnosis and personalized treatment are important for skin problems in women with PCOS.

Obesity increases the risk of developing polycystic ovary syndrome, and weight loss can improve the condition.

New hormonal contraceptives are safer, have fewer side effects, and offer health benefits for women.

PCOS is a common hormonal disorder in women, marked by symptoms like hair growth and menstrual issues, and requires personalized treatment.

FPHL is a common, age-related, genetic hair loss with unclear causes and limited treatment options.

Having enough iron improves the effectiveness of a specific hair loss treatment in women.

The conclusion is that managing androgen excess requires long-term treatment, including hormonal contraceptives and androgen blockers, with follow-up after six months.

Women with PCOS often have skin problems like excessive hair, acne, hair loss, and dark patches, which can be treated with hormonal and non-hormonal therapies.

Finasteride can slow hair loss and promote growth in postmenopausal women.

PCOS in teens is hard to diagnose, linked to genetics and lifestyle, and managed with weight loss and medication.

Lifestyle changes improve metabolism and fertility in overweight PCOS patients; anti-obesity drugs show potential but need more research.

Many young women who donate blood have hormonal disorders like excess male hormones and PCOS.